Novel biodegradable polymeric matrix coated cardiovascular stent for controlled drug delivery

Trends in Biomaterials and Artificial Organs

Volumn 20, Issue 2, 2007, Pages 101-110

  Raval, Ankur ^b   Choubey, Animesh ^a   Engineer, Chhaya ^b   Kotadia, Haresh ^b   Kothwala, Devesh ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Sahajanand Medical Technologies   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AIR SUSPENSION; AIR-SUSPENSION COATING; ALTERNATIVE APPROACH; CARDIOVASCULAR STENTS; COATED STENTS; CONTROLLED RELEASE; CORONARY STENTS; DL-LACTIDE; DRUG-ELUTING STENTS; GLYCOLIDE; L-LACTIDE; LOCAL DRUG DELIVERY; MATRIX; NEOINTIMAL HYPERPLASIA; PACLITAXEL; POLY VINYL PYRROLIDONE; POLYMERIC BLENDS; POLYMERIC MATRICES; SEM;

BIODEGRADABLE POLYMERS; COATINGS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCANNING ELECTRON MICROSCOPY;

CONTROLLED DRUG DELIVERY;

EID: 77956197551     PISSN: 09711198     EISSN: 09711198     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Serruys, P. W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V., Materne, P., et al. (1994). A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med, 331:489-495.
2. Fischman, D. L., et al. Fischman, D. L., Leon, M. B., Baim, D. S., Schatz, R. A., Savage, M. P., Penn, I., Detre, K., Veltri, L., Ricci, D., Nobuyoshi, M., et al. (1994). A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med, 331:496-501.
3. Nobuyoshi, M., Kimura, T., Ohishi H. et al. (1991). Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll. Cardiol, 17 (2):433-439.
4. Chorny, M., Fishbein, I. and Golomb, G. (2000). Drug Delivery Systems for Treatment of Restenosis. Crit Rev Ther Drug Carrier Syst, 17 (3):249-284.
5. Ferrell, M., Fuster, V., Gold, H. K., et al. (1992). A dilemma for the 1990s: choosing appropriate experimental models for the prevention of restenosis. Circulation, 85:1630-1631.
6. Lafont, A., Faxon, D. (1998). Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials? Cardiovasc Res, 39:50-59.
7. Lincoff, A. M., Topol, E. J., Ellis, S. G. (1994). Local drug delivery for the prevention of restenosis: fact, fancy, and future. Circulation, 90:2070-2084.
8. Topol, E. J., Serruys P. W. (1998). Frontiers in interventional cardiology. Circulation, 98:1802-1820.
9. Axel, D. I., Kunert, W., Goggelmann, C., et al. (1997). Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997, 96:636-645.
10. van der Giessen, W. J., Lincoff, A. M., Schwartz, R. S., et al. (1996). Marked inflammatory sequelae to implantation of biodegradable and non-biodegradable polymers in porcine coronary arteries. Circulation, 94:1690-1697.
11. Sollott, S. J., Cheng, L., Pauly, R. R., et al. (1995). Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest, 95:1869-1876.
12. Drachman, D. E., Edelmam, E. R., Seifert, P., et al. (2000). Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over 6 months. J Am Coll Cardiol, 36:2325-2332.
13. Shive, M. S., Anderson, J. M. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 28:5-24.
14. Panyam, J., Dali, M. M., Sahoo, S. K., Ma W, Chakravarthi, S. S., Amidon, G. L., Levy, R. J., L Vinod. (2003). Polymer degradation and in vitro release of a model protein from poly (D, L-lactide-co-glycolide) nano and microparticles. Journal of Controlled Release, 92:173-187.
15. Pitt, C. G. (1990). Poly-caprolactone and its co-polymers, Biodegradable Polymers as Drug Delivery Systems. New York: Dekker. pp. 71-119.
16. Pitt, C. G., Andrady, A. L., Bao Y T and Sarnuei, N. K. P. (1987). Estimation of the rate of drug diffusion in polymers Controlled Release Technology, Pharmaceutical Applications, ACS 348 ed P I Lee and W R Good (American Chemical Society); pp. 49-77.
17. Chappa, et al. Coating method; United States Patent 6, 709, 712, March 23, 2004.
18. Jayaraman. Process for coating a surface of a stent. United States Patent 6, 517, 889 February 11, 2003.
19. G Avades TY: The mechanisms of coronary restenosis: insights from experimental models. J Exp Path 2000, 81:63-88 (RHH library).
20. Gershlick. (2002). Treating atherosclerosis: local drug delivery from laboratory studies to clinical trials. Atherosclerosis, 160:259-271.
21. Wurster, D. E. (1959). Air suspension technique of coating drug particles. Journal of American Pharmaceutical Association, 48:451-454.
22. Jones, D. (1994). Air suspension coating for multiparticulates. Drug development and industrial pharmacy, 20 (20):3175-3206.
23. Jones, DM. (1995). Fluidized bed wurster processing: part 2. Pharm Manu Rev, 7 (1):2-4.
24. Cutright, D. E., Bienvenido, P., Beasly, J. D., Larsen, W. J. (1974). Degradation rates of polymers and copolymers of polylactic and polyglycolic acids. Oral Surg. Oral Med. Oral Pathol, 37:142.
25. Agrawal, C. M., Niederauer, G. G., Micallef, D. M., Athanasiou, K. A. (1995). The use of PLA-PGA polymers in orthopedics. In: Wise DL, Trantolo DJ, Altobelli DE, Yaszemski MJ, Greser JD, Schwartz ER. editors. Encyclopedic handbook of biomaterials and bioengineering Part A. Materials, vol. 2. New York: Marcel Dekker. pp. 1055-1089.
26. Dickers, K. J., Milroy, G. E., Huatan, H. and Cameron, R. E. The Use of Biodegradable Polymers in Drug Delivery Systems to Provide Pre-Programmed Release. Cambridge Centre for Medical Materials, Department of Materials Science and Metallurgy, University of Cambridge; The Drug Delivery Companies Report Autumn/Winter 2002.